Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Alignment Healthcare is lead sponsor; 0 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 8-K2026-10-08Current report (material event)
- SCHEDULE 13G/A2026-10-05SCHEDULE 13G/A
- SCHEDULE 13G2026-08-13SCHEDULE 13G
- SCHEDULE 13G2026-07-31SCHEDULE 13G
- 10-Q2026-07-30Quarterly report
- 8-K2026-07-30Current report (material event)
- SCHEDULE 13G/A2026-07-27SCHEDULE 13G/A
- 8-K2026-06-09Current report (material event)
- SCHEDULE 13G/A2026-05-15SCHEDULE 13G/A
- SCHEDULE 13G/A2026-05-15SCHEDULE 13G/A
- DEFA14A2026-05-12DEFA14A
- 8-K2026-05-12Current report (material event)
- 10-Q2026-04-30Quarterly report
- 8-K2026-04-30Current report (material event)
- SCHEDULE 13G/A2026-04-24SCHEDULE 13G/A
- ARS2026-04-24Annual report to holders
- DEFA14A2026-04-24DEFA14A
- DEF 14A2026-04-24Proxy statement
- SCHEDULE 13G/A2026-03-26SCHEDULE 13G/A
- 8-K2026-03-04Current report (material event)
- 424B72026-03-03424B7
- S-3ASR2026-03-02S-3ASR
- 10-K2026-02-27Annual report
- 8-K2026-02-26Current report (material event)
- SCHEDULE 13G/A2026-02-17SCHEDULE 13G/A
- SCHEDULE 13G/A2026-02-10SCHEDULE 13G/A
- SCHEDULE 13G2026-02-05SCHEDULE 13G
- SCHEDULE 13G/A2026-01-30SCHEDULE 13G/A
- 8-K2026-01-12Current report (material event)
- S-82025-12-22Employee stock plan
- SCHEDULE 13G/A2025-11-14SCHEDULE 13G/A
- SCHEDULE 13G2025-11-12SCHEDULE 13G
- SCHEDULE 13G/A2025-11-05SCHEDULE 13G/A
- 10-Q2025-10-30Quarterly report
- 8-K2025-10-30Current report (material event)
- SCHEDULE 13G2025-10-17SCHEDULE 13G
- SCHEDULE 13G2025-09-24SCHEDULE 13G
- SCHEDULE 13G/A2025-09-24SCHEDULE 13G/A
- 8-K2025-09-09Current report (material event)
- SCHEDULE 13G2025-08-14SCHEDULE 13G
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.